Copy Paste Quotes

Final frontier for meds? UK startup sends drug-making into space

BioOrbit hopes drug-crystallisation technology will lead to self-injected cancer treatment that could save millions

Onboard a SpaceX flight last week was a remarkable piece of cargo – a hi-tech box destined for the International Space Station to grow ultra-pure protein crystals, with the aim of producing self-injected cancer drugs.

A British startup, BioOrbit, has developed the drug-crystallisation technology at its labs in London and launched Box-E, a compact unit the size of a microwave, on the 15 May rocket from Kennedy Space Center in Florida.

Continue reading...

May 23, 2026 Pharmaceuticals industry Business Technology startups

Need the full article?

Use the dedicated news page for the summary, then jump straight to the original source when you want the complete story.